These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7998507)

  • 21. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
    Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
    Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder.
    Moutzouris G; Barbatis C; Plastiras D; Mertziotis N; Katsifotis C; Presvelos V; Theodorou C
    Scand J Urol Nephrol; 1999 Feb; 33(1):27-30. PubMed ID: 10100360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subsequent upper urothelial cancer following bladder tumor].
    Kuruma H; Ao T; Murayama M; Mizoguchi H; Koshiba K
    Hinyokika Kiyo; 2002 Apr; 48(4):199-202. PubMed ID: 12048930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher than expected association of clinical prostate and bladder cancers.
    Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
    J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for upper tract recurrence in patients undergoing long-term surveillance for stage ta bladder cancer.
    Canales BK; Anderson JK; Premoli J; Slaton JW
    J Urol; 2006 Jan; 175(1):74-7. PubMed ID: 16406874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome.
    Holmäng S; Johansson SL
    Cancer; 2004 Aug; 101(4):741-7. PubMed ID: 15305404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metacronous transitional cell carcinoma of the prostatic urethra in a patient with history of nephroureterectomy for upper urinary tract urothelial tumor].
    Cruz Guerra NA; del Valle Manteca A; Zamora Martínez T; Tarroc Blanco A
    Arch Esp Urol; 2004 Dec; 57(10):1125-7. PubMed ID: 15714851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia.
    Dragicevic D; Djokic M; Pekmezovic T; Micic S; Hadzi-Djokic J; Vuksanovic A; Simic T
    BJU Int; 2007 Jun; 99(6):1357-62. PubMed ID: 17346272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
    Chou YH; Huang CH
    Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.